NASDAQ · Financial Statements
Icosavax, Inc. (ICVX) Financial Statements
$15.31
NASDAQ: ICVX
Market Cap $769.04M
Overview Financials Dividend Icosavax, Inc. most recently reported annual revenue of $1.0M, net profit of $-88.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 Revenue $0 $2.0M $8.0M $1.0M Operating Profit $-5.0M $-19.0M $-66.0M $-95.0M Net Profit $-5.0M $-19.0M $-68.0M $-88.0M EPS $-0.51 $-6.67 $-3.78 $-2.23 Op Margin — -1157.8% -844.2% -16333.0%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 Total Assets $23.0M $16.0M $288.0M $239.0M Total Liabilities $32.0M $43.0M $9.0M $21.0M Cash $23.0M $13.0M $279.0M $59.0M Borrowings $0 $5.0M $0 $9.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 Operating Cash Flow $-5.0M $-14.0M $-39.0M $-62.0M Investing Cash Flow $0 $0 $-2.0M $-181.0M Financing Cash Flow $27.0M $7.0M $305.0M $10.0M Net Cash Flow $22.0M $-8.0M $265.0M $-221.0M Free Cash Flow $-5.0M $-14.0M $-40.0M $-73.0M
Valuation & Return Ratios
Metric Value PEG Ratio -47.24 EV / EBITDA -7.63 FCF Yield -9.46% Quick Ratio 16.24 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock